北京時(shí)間3月29日至31日，由美國(guó)心臟病學(xué)會(huì)（ACC）舉辦的心血管領(lǐng)域盛會(huì)——ACC.25學(xué)術(shù)會(huì)議將在美國(guó)芝加哥隆重舉行。在為期三天的會(huì)議中，將有近百項(xiàng)中國(guó)研究進(jìn)行匯報(bào)展示。這些研究涵蓋心血管疾病預(yù)防、診斷新技術(shù)、治療新策略等多個(gè)關(guān)鍵領(lǐng)域，凝聚著中國(guó)科研團(tuán)隊(duì)的智慧與心血，彰顯了我國(guó)心血管醫(yī)學(xué)領(lǐng)域的深厚積淀與蓬勃發(fā)展。POCKETIN對(duì)此進(jìn)行了整理，讓我們拭目以待！如有遺漏或錯(cuò)誤，歡迎留言指正。

03月29日

1020 - Cardiac Arrhythmias 01
北京時(shí)間：22:30
[Board 12] PATTERNS OF POST-ABLATION RECURRENCE AND ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
心房顫動(dòng)患者消融術(shù)后的復(fù)發(fā)模式與不良心血管事件結(jié)局

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 李思彤

1021 - Cardiovascular Disease Prevention 01
北京時(shí)間：22:30
[Board 21] EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES (EXACOS-CV): ONE IN THREE COPD PATIENTS EXPERIENCED CARDIOPULMONARY EVENTS DURING FOLLOW-UP
慢性阻塞性肺疾病加重與心血管疾病（EXACOS-CV）研究：三分之一的慢性阻塞性肺部疾病患者在隨訪時(shí)發(fā)生了心肺事件

Laurence Somerville、李新立，南京醫(yī)科大學(xué)第一附屬醫(yī)院

[Board 28] ASSOCIATIONS BETWEEN SEX, PREHOSPITAL DELAY, AND UNFAVORABLE IN-HOSPITAL OUTCOMES AMONG PATIENTS WITH ACUTE CORONARY SYNDROMES: FINDINGS FROM THE CHINESE CARDIOVASCULAR ASSOCIATION (CCA) DATABASE-CHEST PAIN CENTERREGISTRY
來(lái)自CCA胸痛中心注冊(cè)數(shù)據(jù)庫(kù)的研究結(jié)果：急性冠脈綜合征患者的性別、院前延誤與不良住院結(jié)局的關(guān)系

上海復(fù)旦大學(xué)附屬中山醫(yī)院 臧童童

[Board 33] TAFOLECIMAB IN CHINESE PATIENTS WITH DIABETES MELLITUS: A POOLED ANALYSIS OF EFFICACY AND SAFETY DATA FROM PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIALS
TAFOLECMAB在中國(guó)糖尿病患者中的應(yīng)用：來(lái)自3期隨機(jī)、安慰劑對(duì)照試驗(yàn)的有效性和安全性數(shù)據(jù)的匯總分析

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 申華

[Board 35] EFFECT OF APROCITENTAN ON BLOOD PRESSURE AND ALBUMINURIA IN PATIENTS WITH RESISTANT HYPERTENSION TREATED WITH SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2I)
Aprocitentan對(duì)進(jìn)行SGLT2I治療的頑固性高血壓患者血壓和蛋白尿的影響

上海交通大學(xué)醫(yī)學(xué)院附屬瑞金醫(yī)院 王繼光

902 - Genetics and Genomics to Optimize Cardiovascular Health
北京時(shí)間：22:30
ASSOCIATION OF PCSK9 GENE POLYMORPHISMS WITH ISCHEMIC EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: A LONG-TERM PROSPECTIVE COHORT STUDY
PCSK9基因多態(tài)性與冠狀動(dòng)脈疾病患者缺血事件的相關(guān)性：一項(xiàng)長(zhǎng)期前瞻性隊(duì)列研究

中國(guó)醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)院阜外醫(yī)院 嚴(yán)凱倫

DECODING GENETIC INSIGHTS INTO CARDIOVASCULAR HEALTH: POLYGENIC RISK SCORE FROM LIFE’S ESSENTIAL 8 AND DISCOVERY OF A NOVEL GLYCEMIC GENE IN THE TAIWAN BIOBANK
解讀心血管健康的遺傳見(jiàn)解：從“生命8要素”多基因風(fēng)險(xiǎn)評(píng)分及臺(tái)灣生物庫(kù)中新型血糖基因的發(fā)現(xiàn)血糖基因

國(guó)立臺(tái)灣大學(xué)流行病與預(yù)防醫(yī)學(xué)研究所 Po-Jui Lai

1029 - Heart Failure and Cardiomyopathies 01
北京時(shí)間：22:30
[Board 181] MULTI-FREQUENCY PHASE ANGLE AND SURVIVAL IN CHRONIC HEART FAILURE PATIENTS: A PROSPECTIVE, OBSERVATIONAL STUDY
多頻相位角與慢性心力衰竭患者生存率的關(guān)系：一項(xiàng)前瞻性觀察性研究的結(jié)果

重慶醫(yī)科大學(xué)附屬第一醫(yī)院 黃畢

1022 - Featured Fields 01
北京時(shí)間：22:30
[Board 58] TOTAL BODY WATER TO LEAN BODY MASS RATIO PREDICTS MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE: A PROSPECTIVE, OBSERVATIONAL STUDY
身體總水分與瘦體重比率預(yù)測(cè)慢性心力衰竭患者的死亡率：一項(xiàng)前瞻性觀察研究

重慶醫(yī)科大學(xué)附屬第一醫(yī)院 黃畢

1274 - Valvular Diseases 01
北京時(shí)間：22:30
[Board 128] FEMALE REPRODUCTIVE FACTORS AND RISK OF DEGENERATIVE VALVULAR HEART DISEASE
女性生殖因素與退行性瓣膜性心臟病的風(fēng)險(xiǎn)

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Xinli Guo

03月30日

1047 - Coronary, Peripheral and Structural Interventions 02
北京時(shí)間：00:00
[Board 112] SAFETY AND EFFICACY OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A REAL-WORLD PROPENSITY SCORE MATCHING STUDY
IVABRADINE治療急性心肌梗死患者的安全性和有效性：真實(shí)世界傾向評(píng)分匹配研究

天津醫(yī)科大學(xué)第二醫(yī)院 顧天舒

1049 - Heart Failure and Cardiomyopathies 02
北京時(shí)間：00:00
[Board 129] PRESSURE OVERLOAD INDUCES MYOCARDIAL INSULIN RESISTANCE VIA INCREASING THE AT1R-ERK-TRIM72 PATHWAY-MEDIATED DEGRADATION OF INSULIN RECEPTOR
壓力超負(fù)荷通過(guò)增加AT1R-ERK-TRIM72通路介導(dǎo)的胰島素受體降解誘導(dǎo)心肌細(xì)胞胰島素抵抗

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Qingqing Zhao

[Board 132] MAF1 AMELIORATES CARDIAC FIBROSIS BY REGULATING SFRP2 VIA INTERCELLULAR COMMUNICATION
MAF1通過(guò)細(xì)胞間通訊調(diào)節(jié)SFRP2改善心肌纖維化

中山大學(xué)附屬第一醫(yī)院 李嘉泳

1045 - Ischemic Heart Diseases 02
北京時(shí)間：00:00
[Board 73] THE VALUE OF PLASMA IMMUNOPROTEASOME FOR PREDICTING CORONARY COLLATERAL CIRCULATION IN ST-ELEVATION MYOCARDIAL INFARCTION
血漿免疫蛋白酶體在預(yù)測(cè)ST段抬高型心肌梗死（STEMI）冠狀動(dòng)脈側(cè)支循環(huán)中的價(jià)值

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 張東鳳

1048 - Vascular Diseases 02
北京時(shí)間：00:00
[Board 116] A PHASE 1, SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SRSD107 IN HEALTHY ADULT SUBJECTS
SRSD107的1期單次遞增劑量試驗(yàn)：在健康成年受試者中，評(píng)估SRSD107的安全性、耐受性、藥代動(dòng)力學(xué)和藥效學(xué)特性

靖因藥業(yè) 于沛川；首都醫(yī)科大學(xué)附屬北京天壇醫(yī)院 王維聰

965 - Hypertrophic Cardiomyopathy: Imaging, Therapeutic Options and Biomarkers
北京時(shí)間：00:54
PROGNOSTIC VALUE OF ANGIOGRAPHY-DERIVED INDEX OF MICROVASCULAR RESISTANCE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
血管造影衍生的微循環(huán)阻力指數(shù)對(duì)肥厚型心肌病患者的預(yù)后價(jià)值

浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 蔣峻

928 - ACC Complex Clinical Cases: Pulmonary Vascular Disease (Session 1)
北京時(shí)間：01:00
A CASE OF CBLC TYPE METHYLMALONIC ACIDURIA WITH PULMONARY HYPERTENSION AS THE FIRST MANIFESTATION
1例以肺動(dòng)脈高壓為首發(fā)癥狀的CBLC型甲基丙二酸尿癥患者

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 段安琪

1066 - Ischemic Heart Diseases 03
北京時(shí)間：01:30
[Board 77] PROGNOSTIC VALUE OF OBSTRUCTIVE SLEEP APNOEA IN PATIENTS WITH ACUTE CORONARY SYNDROME IN RELATION TO LIPOPROTEIN(A) LEVEL
急性冠狀動(dòng)脈綜合征患者中阻塞性睡眠呼吸暫停的預(yù)后價(jià)值與脂蛋白(a)水平的關(guān)系

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Yuyao Qiu

1063 - Featured Fields 03
北京時(shí)間：01:30
[Board 62] INTERVENTION THERAPY VERSUS CONSERVATIVE THERAPY OF NON-ST ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH DEMENTIA : A MULTI-CENTER REAL-WORLD STUDY
在合并癡呆的非ST段抬高型心肌梗死（NSTEMI）患者中對(duì)比介入治療與保守治療的療效：一項(xiàng)多中心真實(shí)研究

天津醫(yī)科大學(xué)第二醫(yī)院 Rongxin Guo

1083 - Cardiovascular Disease Prevention 04
北京時(shí)間：03:00
[Board 20] ASSOCIATION OF FRAILTY AND HIGH SENSITIVITY C-REACTIVE PROTEIN WITH CARDIOVASCULAR DISEASE IN MIDDLE-AGED AND OLDER ADULTS: A NATIONWIDE PROSPECTIVE COHORT STUDY
中老年人衰弱和高敏C反應(yīng)蛋白與心血管疾病的關(guān)系：一項(xiàng)全國(guó)性前瞻性隊(duì)列研究

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 劉孟璐

[Board 22] PREDICTIVE VALUE OF MULTIPLE INSULIN RESISTANCE BIOMARKERS FOR CARDIOVASCULAR EVENTS IN ACS PATIENTS WITH DIFFERENT GLUCOSE METABOLISM STATUSES
在不同糖代謝狀態(tài)下，多種胰島素抵抗生物標(biāo)志物對(duì)ACS患者心血管事件的預(yù)測(cè)價(jià)值

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Kexin Zhang

1091 - Heart Failure and Cardiomyopathies 04
北京時(shí)間：03:00
EXPLORING RISK FACTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH DIFFERENT TYPES OF SYNDROMIC AND METABOLIC CARDIOMYOPATHY
不同類型綜合征和代謝性心肌病患者心血管事件危險(xiǎn)因素的探討

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 楊晴

CHARACTERISTICS AND PREDICTORS OF CARDIAC OUTCOMES IN PATIENTS WITH SYNDROMIC AND METABOLIC CARDIOMYOPATHIES
綜合征和代謝性心肌病患者心臟結(jié)局的特征和預(yù)測(cè)因素

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 楊晴

1089 - Coronary, Peripheral and Structural Interventions 04
北京時(shí)間：03:00
[Board 111] INVASIVE OR CONSERVATIVE MANAGEMENT OF CHRONIC CORONARY DISEASE PATIENTS WITH A HISTORY OF CORONARY HEART DISEASE: INSIGHTS FROM THE ISCHEMIA TRIALS
有冠心病病史的慢性冠心病患者侵入性或保守治療：來(lái)自ISCHEMIA試驗(yàn)的見(jiàn)解

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 周蕓

1277 - Valvular Diseases 04
北京時(shí)間：03:00
[Board 122] ASSOCIATIONS BETWEEN SWEETENED BEVERAGES CONSUMPTION, DEGENERATIVE VALVULAR HEART DISEASE, AND RELATED EVENTS: A PROSPECTIVE STUDY FROM UK BIOBANK
飲用含糖飲料、退行性瓣膜性心臟病和相關(guān)事件之間的關(guān)聯(lián)：英國(guó)生物庫(kù)的一項(xiàng)前瞻性研究

中南大學(xué)湘雅二醫(yī)院 朱兆偉

938 - Critical Care Cardiology Perspectives: Shocking Headlines in Cardiogenic Shock
北京時(shí)間：03:30
MACHINE LEARNING FOR PREDICTING THE PROGNOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
應(yīng)用機(jī)器學(xué)習(xí)預(yù)測(cè)AMI合并心源性休克患者的預(yù)后

重慶醫(yī)科大學(xué)附屬第一醫(yī)院 黃畢

937 - Emerging Therapeutic Insights For Valvular Heart Disease Management
北京時(shí)間：03:30
PREDICTION MODEL FOR SUPRA THRESHOLD CEREBRAL ISCHEMIC LESION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT
經(jīng)導(dǎo)管主動(dòng)脈瓣置換術(shù)后超閾值腦缺血損傷的預(yù)測(cè)模型

浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 范嘉祺

1104 - Cardiovascular Disease Prevention 05
北京時(shí)間：04:30
[Board 19] BODY ROUNDNESS INDEX AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASES INCIDENCE AMONG US ADULTS
美國(guó)成年人身體圓度指數(shù)與動(dòng)脈粥樣硬化性心血管疾病發(fā)病率的關(guān)聯(lián)

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Jiayi Yi

[Board 25] OLIVE OIL CONSUMPTION WITH RISK OF ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE COHORTS
橄欖油攝入與全因死亡率及特定病因死亡風(fēng)險(xiǎn)之間的關(guān)系：一項(xiàng)系統(tǒng)綜述和潛在相關(guān)性薈萃分析

中南大學(xué)湘雅二醫(yī)院 Yu Feng

[Board 30] ASSOCIATIONS OF A HEALTHY BEVERAGE SCORE WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY AMONG U.S. ADULTS
健康飲料評(píng)分與美國(guó)成年人全因及心血管死亡率的關(guān)聯(lián)

中南大學(xué)湘雅二醫(yī)院 Yu Feng

[Board 39] ASSOCIATIONS BETWEEN PLANT-BASED DIETS AND TOTAL MORTALITY AMONG PARTICIPANTS WITH CARDIOMETABOLIC DISEASES
植物性飲食與心臟代謝性疾病患者總死亡率的關(guān)系

中南大學(xué)湘雅二醫(yī)院 Bohao Tan

1108 - Ischemic Heart Diseases 05
北京時(shí)間：04:30
[Board 76] PROGNOSTIC IMPLICATIONS OF OBSTRUCTIVE SLEEP APNEA IN ACUTE CORONARY SYNDROME BY METABOLIC SYNDROME STATUS
根據(jù)代謝綜合征狀態(tài)分析阻塞性睡眠呼吸暫停對(duì)ACS患者預(yù)后的影響

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Xiaochen Liu

[Board 77] CORONARY ANGIOGRAPHY VERSUS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR CORONARY ARTERY EVALUATION IN PATIENTS WITH HEART FAILURE
冠狀動(dòng)脈造影與冠狀動(dòng)脈計(jì)算機(jī)斷層掃描血管造影在心力衰竭患者冠狀動(dòng)脈評(píng)估中的比較

重慶醫(yī)科大學(xué)附屬第一醫(yī)院 黃畢

1107 - Multimodal Imaging 05
北京時(shí)間：04:30
[Board 72] VALIDATION OF A DEEP LEARNING-BASED ALGORITHM IN QUANTIFYING TRICUSPID VALVE REGURGITATION
基于深度學(xué)習(xí)的機(jī)器算法在量化三尖瓣反流方面的驗(yàn)證

香港中文大學(xué)威爾士親王醫(yī)院 Chenxu Zhao

236 - Risky Business: Tackling Lipids in High-Risk Populations
北京時(shí)間：04:30
Case Presentation: Hypertriglyceridemia and Primary Prevention
病例介紹：高甘油三酯血癥與一級(jí)預(yù)防

香港 Ngai-Yin Chan

1105 - Featured Fields 05
北京時(shí)間：04:30
[Board 50] VARIATIONS IN TREATMENT PATHWAYS AND OUTCOMES RELATED TO INITIAL PRESENTATIONS IN TAKOTSUBO SYNDROME
與Takotsubo綜合征初始表現(xiàn)相關(guān)的治療途徑和結(jié)局差異

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Mingxiao Li

[Board 52] EFFECT OF XUEBIJING ON THE PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY SEVERE INFECTION
血必凈對(duì)急性心肌梗死合并嚴(yán)重感染患者預(yù)后的影響

天津醫(yī)科大學(xué)第二醫(yī)院 Yukun Zhang

311 - Pushing the Envelope on Permissive Cardiotoxicity: How Far Can We Go?
北京時(shí)間：21:00
Are We Okay With Rechallenge in Cases of 5FU Induced Vasospasm?
在5FU誘導(dǎo)的血管痙攣病例中，我們可以接受再激發(fā)試驗(yàn)嗎？

北京大學(xué)中日友好醫(yī)院 孫藝紅

1123 - Cardiac Arrhythmias 06
北京時(shí)間：22:00
[Board 1] CATHETER ABLATION FOR ATRIAL FIBRILLATION WITH NON-MODIFIABLE RECURRENCE RISK FACTORS: RESULTS FROM THE CABANA TRIAL
導(dǎo)管消融在具有不可改變復(fù)發(fā)風(fēng)險(xiǎn)因素的房顫患者中的療效：CABANA試驗(yàn)結(jié)果

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Zhen Wang

1130 - Coronary, Peripheral and Structural Interventions 06
北京時(shí)間：22:00
[Board 100] PERCUTANEOUS CORONARY INTERVENTION VERSUS OPTIMAL-MEDICAL-THERAPYIN PATIENTS WITH BORDERLINE CORONARY LESIONSAT HIGH RISK FOR BLEEDING
高出血風(fēng)險(xiǎn)的冠狀動(dòng)脈臨界病變患者PCI vs. 最佳藥物治療

天津醫(yī)科大學(xué)第二醫(yī)院 Jiayu Wang

[Board 102] THE EFFECT OF PERCUTANEOUS CORONARY INTERVENTIONON PATIENTSWITH FRAILTY AND NON-ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION
PCI治療對(duì)虛弱合并NSTEMI患者的影響

天津醫(yī)科大學(xué)第二醫(yī)院 Sutao Hu

[Board 103] LONG-TERM CLINICAL OUTCOMES OFAPOLYMER-FREE SIROLIMUS-ELUTING STENT IN REAL-WORLD
無(wú)聚合物西羅莫司洗脫支架在真實(shí)世界中的長(zhǎng)期臨床結(jié)局

天津醫(yī)科大學(xué)第二醫(yī)院 Sutao Hu

[Board 105] COMPARISON BETWEEN BUMA AND RESOLUTE CORONARY STENT SYSTEMON CLINICAL EFFICACY
BUMA與RESOLUTE冠狀動(dòng)脈支架系統(tǒng)臨床療效比較

天津醫(yī)科大學(xué)第二醫(yī)院 Mayi Zheng

[Board 99] LONG-TERM PERFORMANCE OF THE SECOND GENERATION DRUG-ELUTING STENTS IN REAL-WORLD CLINICAL PRACTICE: THREE-YEAR CLINICAL OUTCOMES FROM A RETROSPECTIVE MULTICENTER DATASET
第二代藥物洗脫支架在真實(shí)世界臨床實(shí)踐中的長(zhǎng)期療效：一項(xiàng)多中心、回顧性研究的3年臨床結(jié)果

天津醫(yī)科大學(xué)第二醫(yī)院 Jiayi Ren

1128 - Ischemic Heart Diseases 06
北京時(shí)間：22:00
[Board 80] THE RELATIONSHIP BETWEEN NEUTROPHIL-PERCENTAGE-TO-ALBUMIN RATIO (NPAR) AND LONG-TERM ADVERSE OUTCOMES IN PATIENTS WITH MYOCARDIAL INFARCTION AND NON-OBSTRUCTIVE CORONARY ARTERIES (MINOCA)
非阻塞性冠狀動(dòng)脈心肌梗死（MINOCA）患者中性粒細(xì)胞百分比/白蛋白比值（NPAR）與長(zhǎng)期不良結(jié)局的關(guān)系

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Yanwen Fang

[Board 81] COMBINED RISK ESTIMATES OF METABOLIC RISK FACTORS AND CORONARY ANGIOGRAPHY-DERIVED INDEX OF MICROCIRCULATORY RESISTANCE IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION
STEMI患者代謝危險(xiǎn)因素和冠脈造影衍生的微循環(huán)阻力指數(shù)（Angio-IMR）的綜合風(fēng)險(xiǎn)評(píng)估

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Qian Guo

[Board 84] THE LONG-TERM PROGNOSTIC VALUE OF THE FRAMINGHAM RISK SCORING IN PATIENTS WITH MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES
FRAMINGHAM風(fēng)險(xiǎn)評(píng)分對(duì)MINOCA患者長(zhǎng)期預(yù)后的預(yù)測(cè)價(jià)值

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Hao Zhang

[Board 85] RADIOMIC FEATURES FROM NON-CONTRAST CINE CARDIAC MRI PREDICT LONG-TERM ST-ELEVATION MYOCARDIAL INFARCTION OUTCOMES
非對(duì)比CINE心臟磁共振成像的放射學(xué)特征在預(yù)測(cè)STEMI長(zhǎng)期預(yù)后中的價(jià)值

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Wen Zheng

1125 - Featured Fields 06
北京時(shí)間：22:00
[Board 42] OPPOSITE ASSOCIATIONS OF SERUM URIC ACID WITH ABDOMINAL AORTIC ANEURYSM IN DIABETIC VS. NON-DIABETIC POPULATION
糖尿病 vs. 非糖尿病人群血清尿酸與腹主動(dòng)脈瘤的相反關(guān)系

江西醫(yī)學(xué)院第二附屬醫(yī)院 Ao Shi

1144 - Cardiovascular Disease Prevention 07
北京時(shí)間：23:30
[Board 20] MONOCYTE-TO-APOLIPOPROTEIN A1 RATIO, A NOVEL BIOMARKER FOR PREDICTING DEATH AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A LARGE-SCALE AND LONG-TERM FOLLOW-UP STUDY
新型生物標(biāo)志物單核細(xì)胞與載脂蛋白A1比值在預(yù)測(cè)PCI患者死亡中的價(jià)值：一項(xiàng)大規(guī)模長(zhǎng)期隨訪研究

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 嚴(yán)凱倫

[Board 33] 24 HOUR AMBULATORY BLOOD PRESSURE CONTROL IN CHINA: A NATIONWIDE DATABASE REPORT
中國(guó)24小時(shí)動(dòng)態(tài)血壓控制狀況：全國(guó)數(shù)據(jù)庫(kù)報(bào)告

北京大學(xué)人民醫(yī)院高血壓數(shù)據(jù)調(diào)查組（HDIG） JING LIU

1152 - Heart Failure and Cardiomyopathies 07
北京時(shí)間：23:30
[Board 134] TYPE 2 DIABETES MELLITUS, PREDIABETES, AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY AFTER SEPTAL MYECTOMY
間隔肌切除術(shù)后梗阻性肥厚型心肌病患者的2型糖尿病、糖尿病前期和心血管結(jié)局

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Tao Lu

1151 - Vascular Diseases 07
北京時(shí)間：23:30
[Board 117] COMPARISON OF 3-YEAR CLINICAL OUTCOMES OF AMI PATIENTS: PROMUS PREMIER STENT VS BUMA STENT
AMI患者3年臨床療效比較：PROMUS PREMIER支架 vs. BUMA支架

天津醫(yī)科大學(xué)第二醫(yī)院心內(nèi)科 Shan Cao

[Board 118] PREOPERATIVE AND POSTOPERATIVE DIFFERENCES IN THE RADIAL ARTERY IN PATIENTS UNDERGOING FIRST VERSUS MULTIPLE TRANSRADIAL INTERVENTIONS
首次 vs. 多次經(jīng)橈動(dòng)脈介入治療患者橈動(dòng)脈的術(shù)前和術(shù)后差異

天津市胸科醫(yī)院 司海龍

107 - Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials V
北京時(shí)間：23:45
Comparison Of Angiography-derived Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention Strategies: The FLAVOUR II Trial
血管造影衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)與血管內(nèi)超聲指導(dǎo)的經(jīng)皮冠狀動(dòng)脈介入治療策略比較：FLAVOUR II試驗(yàn)

浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 王建安

03月31日

962 - Complex PCI
北京時(shí)間：00:30
ASSOCIATION BETWEEN ROTATIONAL ATHERECTOMY SPEED AND PERIPROCEDURAL MYOCARDIAL INFARCTION: INSIGHTS FROM THE ROTA CHINA REGISTRY
旋磨速度與圍手術(shù)期心肌梗死的關(guān)系：來(lái)自ROTA CHINA注冊(cè)研究的觀點(diǎn)

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Yuekun Zhang

964 - What's New in the World of Hypertrophic Cardiomyopathy
北京時(shí)間：00:30
PROTEOMIC PROFILING PREDICTS GENE MUTATION IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
應(yīng)用蛋白質(zhì)組學(xué)特征預(yù)測(cè)梗阻性肥厚型心肌病患者的基因突變

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Xinli Guo

965 - Hypertrophic Cardiomyopathy: Imaging, Therapeutic Options and Biomarkers
北京時(shí)間：00:30
PROTEOMIC PROFILING AND ITS ASSOCIATION WITH GENETIC MUTATIONS AND CLINICAL INDICATORS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
梗阻性肥厚型心肌病的蛋白質(zhì)組學(xué)特征及其與基因突變和臨床指標(biāo)的關(guān)系

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Xinli Guo

1165 - Cardiovascular Disease Prevention 08
北京時(shí)間：01:00
EFFECT OF IN-HOSPITAL INITIATION OF ALIROCUMAB ON CLINICAL OUTCOMES IN CHINESE ACUTE CORONARY SYNDROME PATIENTS: A DATABASE-BASED RETROSPECTIVE ANALYSIS
在中國(guó)急性冠狀動(dòng)脈綜合征患者中，院內(nèi)開(kāi)始使用阿利西尤單抗對(duì)臨床結(jié)局的影響：基于數(shù)據(jù)庫(kù)的回顧性分析

中國(guó)人民解放軍總醫(yī)院 陳韻岱

1165 - Cardiovascular Disease Prevention 08
北京時(shí)間：01:00
[Board 36] TRENDS IN RACIAL AND ETHNIC DISPARITIES IN ADVANCED CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AMONG U.S. ADULTS: INSIGHTS FROM NHANES 2011-2020
美國(guó)晚期心血管-腎臟-代謝（CKM）綜合征成年患者中的種族差異：NHANES 2011-2020的觀點(diǎn)

中國(guó)北京清華大學(xué) Huanhuan Yang

1169 - Ischemic Heart Diseases 08
北京時(shí)間：01:00
[Board 80] ONE-YEAR CLINICAL OUTCOMES OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING LONG-TERM REGULAR HEMODIALYSIS VERSUS PERITONEAL DIALYSIS: A RETROSPECTIVE COHORT STUDY
長(zhǎng)期定期血液透析 vs. 腹膜透析患者AMI的1年臨床結(jié)局：一項(xiàng)回顧性隊(duì)列研究

天津醫(yī)科大學(xué)第二醫(yī)院 Hao Zhang

1167 - Pulmonary Vascular Disease 08
北京時(shí)間：01:00
[Board 65] EFFECTS OF COMBINED RIOCIGUAT AND ENDOTHELIN RECEPTOR ANTAGONIST THERAPY IN CHINESE PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
利奧西呱和內(nèi)皮素受體拮抗劑聯(lián)合治療在中國(guó)肺動(dòng)脈高壓患者中的療效

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 段安琪

1166 - Featured Fields 08
北京時(shí)間：01:00
[Board 53] DETECTING ECHOCARDIOGRAPHIC PARAMETERS FROM ELECTROCARDIOGRAMS IN HEMODYNAMICALLY SIGNIFICANT AORTIC REGURGITATION USING DEEP LEARNING
利用深度學(xué)習(xí)從心電圖中檢測(cè)血流動(dòng)力學(xué)顯著性主動(dòng)脈瓣反流的超聲心動(dòng)圖參數(shù)

臺(tái)灣臺(tái)北市立臺(tái)灣大學(xué)醫(yī)院 Meng-Han Tsai

[Board 56] AN INTERPRETABLE MACHINE LEARNING MODEL USING ROUTINE LAB TESTS TO PREDICT 1-YEAR CARDIAC DEATHIN AMI PATIENTS POST-PCI
基于常規(guī)實(shí)驗(yàn)室測(cè)試的可解釋機(jī)器學(xué)習(xí)模型，預(yù)測(cè)AMI患者PCI治療后1年的心臟死亡

天津醫(yī)科大學(xué)第二醫(yī)院 hongya liu

1186 - Cardiovascular Disease Prevention 09
北京時(shí)間：02:30
[Board 31] SLEEP DURATION, DEPRESSION AND CARDIOVASCULAR DISEASE, A NATIONAL COHORT STUDY
睡眠時(shí)長(zhǎng)、抑郁與心血管疾病：一項(xiàng)全國(guó)性隊(duì)列研究

首都醫(yī)科大學(xué)附屬北京友誼醫(yī)院 Shandong Yu

1190 - Ischemic Heart Diseases 09
北京時(shí)間：02:30
[Board 73] SAFETY AND EFFICACY OF ACIPIMOX IN COMBINATION WITH STATINS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND ELEVATED TRIGLYCERIDE LEVELS
阿昔莫司聯(lián)合他汀類藥物治療在甘油三酯水平升高的AMI患者中的安全性和有效性

天津醫(yī)科大學(xué)第二醫(yī)院 顧天舒

[Board 74] COMPARISON OF THE SAFETY AND EFFICACY BETWEEN TICAGRELOR AND CLOPIDOGREL IN MYOCARDIAL INFARCTION PATIENTS WITH FRAILTY : A MULTI-CENTER OBSERVATIONAL STUDY
替格瑞洛 vs. 氯吡格雷治療虛弱心肌梗死患者的安全性和有效性：一項(xiàng)多中心觀察研究

天津醫(yī)科大學(xué)第二醫(yī)院 Rongxin Guo

982 - Exciting Times For Cardiac Imaging: Relevant Clinical and Translational Science
北京時(shí)間：03:00
PLAQUE INFLAMMATION INCREASES PLAQUE VULNERABILITY IN PATIENTS WITH CORONARY ARTERY DISEASE: A 3-VESSEL OPTICAL COHERENCE TOMOGRAPHY STUDY
斑塊炎癥增加冠狀動(dòng)脈疾病患者的斑塊易損性：一項(xiàng)三支血管光學(xué)相干斷層掃描試驗(yàn)

首都醫(yī)科大學(xué)附屬北京安貞醫(yī)院 Xiaochen Liu

981 - Insights Into Chronic Coronary Syndromes
北京時(shí)間：03:00
PROGNOSTIC SIGNIFICANCE OF THE CORONARY MICROCIRCULATORY DYSFUNCTION IN DEFERRED INTERMEDIATE STENOTIC VESSELS
冠狀動(dòng)脈微循環(huán)功能障礙在遲發(fā)性中度血管狹窄患者中的預(yù)后意義

浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 蔣峻

1206 - Cardiac Arrhythmias 10
北京時(shí)間：04:00
[Board 9] LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION COMBINED WITH CRYOBALLOON ABLATION FOR VENTRICULAR TACHYCARDIA
左心室輔助裝置植入聯(lián)合冷凍球囊消融在室性心動(dòng)過(guò)速患者中的應(yīng)用

中南大學(xué)湘雅二醫(yī)院 Shuang Zhang

1215 - Heart Failure and Cardiomyopathies 10
北京時(shí)間：04:00
[Board 142] REAL-WORLD EVALUATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AFTER MYOCARDIAL INFARCTION
在真實(shí)世界中評(píng)估血管緊張素轉(zhuǎn)換酶抑制劑在心肌梗死后射血分?jǐn)?shù)保留的心衰患者中的療效

天津醫(yī)科大學(xué)第二醫(yī)院 顧天舒

1211 - Ischemic Heart Diseases 10
北京時(shí)間：04:00
[Board 73] THE IMPACT OF QISHEN YIQI DRIPPING PILLS ON PROGNOSIS IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH FRAILTY
芪參益氣滴丸對(duì)虛弱急性心肌梗死患者預(yù)后的影響

天津醫(yī)科大學(xué)第二醫(yī)院 Yukun Zhang

[Board 85] SODIUM-DEPENDENT GLUCOSE TRANSPORTERS 2 INHIBITORS IMPROVE THE SHORT-TERM PROGNOSIS IN CHRONIC KIDNEY DISEASE PATIENTS WITH ACUTEMYOCARDIAL INFARCTION
SGLT-2抑制劑可改善合并AMI的慢性腎病患者的短期預(yù)后

天津醫(yī)科大學(xué)第二醫(yī)院 Xue Zhang

1283 - Valvular Diseases 10
北京時(shí)間：04:00
[Board 121] TRANSCATHETER TRICUSPID ANNULOPLASTY USING K-CLIP? IN PATIENTS WITH RIGHT VENTRICULAR-PULMONARY ARTERIAL UNCOUPLING
使用K-CLIP?經(jīng)導(dǎo)管三尖瓣環(huán)成形術(shù)治療右心室-肺動(dòng)脈解偶聯(lián)患者的療效

復(fù)旦大學(xué)附屬中山醫(yī)院 Dawei Lin

1214 - Vascular Diseases 10
北京時(shí)間：04:00
[Board 117] STUDY OF OPTIMIZED HEMOSTASIS AND REHABILITATION STRATEGIES FOR PREVENTION OF RADIAL ARTERY OCCLUSION AFTER RE-TRANSRADIAL INTERVENTION
經(jīng)橈動(dòng)脈再介入術(shù)后預(yù)防橈動(dòng)脈閉塞的優(yōu)化止血與康復(fù)治療策略研究

天津市胸科醫(yī)院 司海龍

1227 - Cardiovascular Disease Prevention 11
北京時(shí)間：22:00
[Board 20] A REAL-WORLD EVALUATION OF SACUBITRIL/VALSARTAN IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH CHARLSON COMORBIDITY INDEX
沙庫(kù)巴曲/纈沙坦在高Charlson合并癥指數(shù)急性心肌梗死患者中的真實(shí)世界評(píng)估

天津醫(yī)科大學(xué)第二醫(yī)院 hongya liu

1231 - Ischemic Heart Diseases 11
北京時(shí)間：22:00
ASSOCIATION OF PSORIASIS AND ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASES: MEDIATING ROLE OF INFLAMMATION AND MICROVASCULAR DYSFUNCTION
銀屑病與冠狀動(dòng)脈疾病患者心血管不良事件的相關(guān)性：炎癥和微血管功能障礙的介導(dǎo)作用

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 黃思?jí)?/p>

1235 - Heart Failure and Cardiomyopathies 11
北京時(shí)間：22:00
[Board 143] DIFFERENCES IN THE EFFICACY OF β-BLOCKER THERAPY AFTER ACUTE MYOCARDIAL INFARCTION IN DIFFERENT TYPES OF HEART FAILURE
不同類型心力衰竭急性心肌梗死后β受體阻滯劑治療的療效差異

天津醫(yī)科大學(xué)第二醫(yī)院 顧天舒

402 - Clinical and Investigative Horizons I
北京時(shí)間：22:00
Effect Of Berberine Hydrochloride On Visceral And Liver Fat In Non-diabetic Individuals With Visceral Adiposity
鹽酸小檗堿對(duì)非糖尿病內(nèi)臟型肥胖患者內(nèi)臟脂肪和肝臟脂肪的影響

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Lubi Lei

1256 - Complex Clinical Cases: Cardiac Arrhythmias 12
北京時(shí)間：23:30
[Board 227] KILL TWO BIRDS WITH ONE STONE-BIVENTRICULAR PACING IMPROVES CARDIAC FUNCTION BY LEADING TO GLOBAL SYNCHRONIZATION AND ELIMINATION OF THE SUPRAVENTRICULAR TACHYCARDIA
一石二鳥(niǎo)：雙心室起搏通過(guò)促進(jìn)整體同步并消除室上性心動(dòng)過(guò)速來(lái)改善心臟功能

北京大學(xué)第一醫(yī)院 Songyun Chu

1239 - Complex Clinical Cases: Multimodal Imaging 11
北京時(shí)間：22:00
PIERCED BY MISFORTUNE: UNRAVELING THE MYSTERY OF A PATIENT WITH RECURRENT INFECTIVE ENDOCARDITIS
被不幸刺穿：揭開(kāi)一例復(fù)發(fā)性感染性心內(nèi)膜炎患者的神秘面紗

香港東區(qū)尤德夫人那打素醫(yī)院 Tin Wah Christopher Lau

1246 - Multimodal Imaging 12
北京時(shí)間：23:30
[Board 89] INTERVENTIONAL TRANSESOPHAGEAL ECHOCARDIOGRAM: FEATURES AND RISKS IN SIMPLE VERSUS COMPLEX STRUCTURAL HEART INTERVENTIONS
介入性經(jīng)食管超聲心動(dòng)圖：簡(jiǎn)單與復(fù)雜結(jié)構(gòu)性心臟病介入治療中的特征和風(fēng)險(xiǎn)

香港中文大學(xué) Chak Yu So

1267 - Heart Failure and Cardiomyopathies 13
北京時(shí)間：23:30
[Board 227] KILL TWO BIRDS WITH ONE STONE-BIVENTRICULAR PACING IMPROVES CARDIAC FUNCTION BY LEADING TO GLOBAL SYNCHRONIZATION AND ELIMINATION OF THE SUPRAVENTRICULAR TACHYCARDIA
在香港一家三級(jí)轉(zhuǎn)診中心進(jìn)行的多學(xué)科心力衰竭項(xiàng)目的1年評(píng)估結(jié)果

香港伊利沙伯醫(yī)院 Esmond Yan Hang Fong

04月01日

1006 - Lipids and Lipoproteins: New Insights on Cardiovascular Cornerstones
北京時(shí)間：00:30
EXCESS APOLIPOPROTEIN B AND FUTURE CARDIOVASCULAR RISK IN PATIENTS WITH PREDIABETES
糖尿病前期患者中載脂蛋白B過(guò)量與未來(lái)心血管疾病風(fēng)險(xiǎn)的關(guān)系

廣東省人民醫(yī)院（廣東省醫(yī)學(xué)科學(xué)院） Huangtao Ruan

1007 - Emerging Evidence in Hypertension Management For Cardiovascular Disease Prevention
北京時(shí)間：00:30
BLOOD PRESSURE AND MORTALITY IN THE ADULTS AGED 80 OR OLDER: A COMPREHENSIVE ANALYSIS OF NATIONAL SURVEYS IN THE UNITED STATES
80歲及以上成年人的血壓和死亡率：美國(guó)全國(guó)調(diào)查的綜合分析

北京清華大學(xué) Huanhuan Yang

1009 - Durable Left Ventreicular Assist Devices: Outcomes and Social Determinants of Health
北京時(shí)間：00:30
AORTIC ROOT STASIS AS MEASURED BY DELTA HOUNSFIELD UNIT OF AORTIC CUSPS ON CARDIAC CT: A NOVEL PREDICTOR OF STROKE AND AORTIC ROOT THROMBOSIS IN PT WITH HM 3 LVAD IMPLANTATION
通過(guò)心臟CT主動(dòng)脈瓣尖的亨氏單位差值（ΔHU）變化測(cè)量主動(dòng)脈根部血流停滯：在植入HM3 LVAD的患者中作為卒中及主動(dòng)脈根部血栓形成的一種新型預(yù)測(cè)指標(biāo)

中國(guó)臺(tái)灣高雄醫(yī)學(xué)大學(xué)附設(shè)醫(yī)院 Min-Fang Chao

1286 - Valvular Diseases 13
北京時(shí)間：01:00
[Board 128] ARTIFICIAL-INTELLIGENCE BASED PREDICTION MODEL FOR THIRTY-DAY MORTALITY OF TAVR PATIENTS IN CHINA: A NATIONAL STUDY FROM NTCVR COHORT
基于人工智能的中國(guó)TAVR患者30天死亡率預(yù)測(cè)模型：來(lái)自NTCVR COHORT的全國(guó)性研究

浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 朱齊豐

434 - Clinical and Investigative Horizons II
北京時(shí)間：02:00
Homogeneous Effects Of Intensive Blood Pressure Control In Patients With Various Frailty Status: A Post-hoc Analysis Of The Esprit Tria
不同虛弱狀態(tài)患者強(qiáng)化血壓控制的同質(zhì)效應(yīng)：Esprit試驗(yàn)的事后分析

中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院 Shitian Li

Efficacy and Safety of SHR-1918, an Angiopoietin-like 3 Monoclonal Antibody, in Combination With Lipid-Lowering Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 2 Trial
一項(xiàng)多中心、隨機(jī)、雙盲、安慰劑對(duì)照2期試驗(yàn)：血管生成素樣蛋白3的單克隆抗體SHR-1918與降脂治療聯(lián)合應(yīng)用對(duì)控制欠佳的高脂血癥患者的療效和安全性
浙江大學(xué)醫(yī)學(xué)院附屬第二醫(yī)院 謝小潔

記錄高光時(shí)刻 · 共鑒學(xué)術(shù)風(fēng)華

如果您將參加此次會(huì)議

敬請(qǐng)聯(lián)系我們

（文章留言或公眾號(hào)私信）

我們將用鏡頭與影像

留存您的卓越風(fēng)采

讓世界共睹中國(guó)智慧

如發(fā)現(xiàn)文內(nèi)有誤請(qǐng)聯(lián)系我們

來(lái)源：ACC.25

POCKETIN 將挑選重點(diǎn)研究，就已發(fā)布結(jié)果邀請(qǐng)專家陸續(xù)解讀

POCKETIN接受投稿，我們將為撰稿作者提供該研究的過(guò)往詳細(xì)資料，資料包括：原文、演講幻燈、官方新聞、演講視頻等素材。并根據(jù)稿件質(zhì)量支付稿費(fèi)。

稿件將發(fā)表在POCKETIN、心關(guān)注微信公眾號(hào)上，并發(fā)表在國(guó)際期刊《翳望》（ISSN 2709-9105）上。同時(shí)，稿件將作為供稿提供給合作單位。

投稿請(qǐng)聯(lián)系：zhengsisi@medicaltelescope.cn 鄭思思

POCKETIN

ACC.25

由蘇州工業(yè)園區(qū)東方華夏心血管健康研究院和醫(yī)望共同發(fā)起的POCKETIN項(xiàng)目將依托人工智能學(xué)術(shù)跟蹤系統(tǒng)，為全國(guó)廣大心血管醫(yī)師帶來(lái)及時(shí)全面的報(bào)道。

項(xiàng)目得到了醫(yī)師報(bào)、梅斯醫(yī)學(xué)、365醫(yī)學(xué)網(wǎng)、健康界、中華醫(yī)學(xué)信息導(dǎo)報(bào)、心關(guān)注、醫(yī)心、嚴(yán)道醫(yī)聲網(wǎng)等單位的大力支持。

▼更多精彩內(nèi)容，請(qǐng)長(zhǎng)按二維碼▼

1. 相關(guān)學(xué)術(shù)信息由醫(yī)望自主研發(fā)的人工智能學(xué)術(shù)跟蹤機(jī)器人提供。

2. 相關(guān)學(xué)術(shù)信息由醫(yī)望提供的醫(yī)學(xué)翻譯機(jī)器人完成翻譯后邀請(qǐng)臨床醫(yī)師進(jìn)行再次校對(duì)。
3. 如有內(nèi)容上的不準(zhǔn)確請(qǐng)微信聯(lián)系我們（zhengsisi@medicaltelescope.cn）

4. 2023年8月起，POCKETIN引入人工智能（ChatGPT、文心一言），專業(yè)編輯攜手AI編輯開(kāi)啟會(huì)議速遞新體驗(yàn)。

全面工作

傳播矩陣

FOLLOW US

• 蘇州工業(yè)園區(qū)東方華夏心血管健康研究院

• 電話：0512-68295918

• 郵箱：info@ccahouse.org

• 網(wǎng)址：https://www.ccahouse.org

• 地址：蘇州工業(yè)園區(qū)水坊路36號(hào)姑蘇會(huì)平江館心臟之家